Category:CT Surgery News
Jump to navigation Jump to search
There is currently no text in this page. You can search for this page title in other pages, .
Pages in category "CT Surgery News"
The following 6 pages are in this category, out of 6 total.
- MC-1 does not reduce cardiovascular and cerebrovascular events in phase 3 MEND-CABG II trial
- MC-1 does not reduce cardiovascular and cerebrovascular events in the phase 3 MEND-CABG II trial
- MEND-CABG II trial does not suggest improved outcomes with the novel drug MC1 in patients undergoing high risk coronary artery bypass surgery